Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_863dddc7125f4b0d446c3223ebaadfab http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5dd388a5130b0bdede0fdfc6c2af6ed |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-866 |
filingDate |
2015-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30e654c948f7d014e6b651f81926ff41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2dc8937f36c1c10cdbe04373b766941 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29faa4f2bec37097c4602fbbb76d9e83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53b6af8c48992a3095d78cd91c44beab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a804f979d7e6ab5f7349016f4d83f17a |
publicationDate |
2017-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3233117-A1 |
titleOfInvention |
Synergistic co-administration of computationally optimized broadly reactive antigens for human and avian h5n1 influenza |
abstract |
The present invention provides co-administration (e.g., immunogenic cocktail and/or prime-boost regimens) of computationally optimized H5N 1 influenza hemagglutinin (HA) polypeptides that. Co-administration of the optimized H5N 1 influenza hemagglutinin (HA) polypeptides facilitates synergistic neutralization of viral infection and provides for improved protective immunity (e.g., a broad reactive immune response) to multiple H5N 1 influenza virus clades and strains. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021198701-A1 |
priorityDate |
2014-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |